Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Short-term Investments (2016 - 2018)

Angiodynamics' Short-term Investments history spans 8 years, with the latest figure at $1.3 million for Q4 2018.

  • For Q4 2018, Short-term Investments rose 7.14% year-over-year to $1.3 million; the TTM value through Nov 2018 reached $1.3 million, up 7.14%, while the annual FY2018 figure was $1.3 million, 8.4% up from the prior year.
  • Short-term Investments reached $1.3 million in Q4 2018 per ANGO's latest filing, roughly flat from $1.3 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $1.8 million in Q1 2014 to a low of $1.2 million in Q4 2016.
  • Average Short-term Investments over 5 years is $1.5 million, with a median of $1.6 million recorded in 2015.
  • Peak YoY movement for Short-term Investments: fell 27.79% in 2017, then increased 11.11% in 2018.
  • A 5-year view of Short-term Investments shows it stood at $1.7 million in 2014, then dropped by 3.47% to $1.6 million in 2015, then dropped by 26.6% to $1.2 million in 2016, then rose by 4.74% to $1.3 million in 2017, then grew by 7.14% to $1.3 million in 2018.
  • Per Business Quant, the three most recent readings for ANGO's Short-term Investments are $1.3 million (Q4 2018), $1.3 million (Q3 2018), and $1.3 million (Q2 2018).